Vaccine immunotherapy for immune suppressed patients

Details for Australian Patent Application No. 2004271930 (hide)

International Classifications

Event Publications

16 March 2006 PCT application entered the National Phase

PCT publication WO2005/025494 Priority application(s): WO2005/025494

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 March 2010 Section 223 Application Received

IRx Therapeutics, Inc. An application to extend the time from 05 Aug 2009 to 05 Mar 2010 in which to pay a renewal fee has been filed . Address for service in Australia - Lord and Company 4 Douro Place West Perth WA 6005 2007

13 May 2010 Section 223 Application Allowed

IRx Therapeutics, Inc. the time in which to pay a renewal fee has been extended to 05 Mar 2010. Address for service in Australia - Lord and Company 4 Douro Place West Perth WA 6005 2005

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.